David Fredrickson, AstraZeneca
WCLC: AstraZeneca builds case for growing ADC pipeline with double wins in advanced lung cancer
As part of its hard pivot to oncology in recent years, AstraZeneca made a big bet on next-gen cancer fighters with a multibillion-dollar deal in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
